封面
市场调查报告书
商品编码
1494878

到 2030 年药用玻璃安瓿市场预测:按产品类型、类型、产能、应用、最终用户和地区进行的全球分析

Pharmaceutical Glass Ampoules Market Forecasts to 2030 - Global Analysis By Product Type, Type, Capacity, Application, End User and By Geography

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据,2024 年全球药用玻璃安瓿市场规模为 148 亿美元,预计在预测期内复合年增长率为 8.9%,到 2030 年将达到 247 亿美元。

药用玻璃安瓿是由玻璃製成的密封管瓶,用于封装和储存液体药物,特别是注射用药物。这些安瓿通常由优质硼硅酸玻璃製成,具有出色的耐化学性和热稳定性,确保封装药品的纯度和稳定性。玻璃材料可防止药物与容器的相互作用并保持药物的功效和安全性。药用玻璃安瓿广泛应用于医院和临床环境,对于安全有效地传递疫苗、注射和其他关键药物至关重要。

根据 CNN 和 OWID 报导,截至 2023 年 3 月 20 日,全球已接种了约 130 亿剂 COVID-19 疫苗,其中美国接种了约 6.72 亿剂。

药品需求增加

药品中单剂量包装的成长趋势与玻璃安瓿的优势完全一致。单剂量包装可最大限度地降低药物污染风险并确保剂量准确。玻璃安瓿为这个不断成长的市场提供了一个方便、安全的解决方案。此外,许多药品,特别是那些源自生物技术或含有敏感成分的药品,需要包装提供出色的保护,以防止水分、空气和劣化等因素的影响。具有优异阻隔性能和化学惰性的玻璃安瓿是这种敏感药品的理想选择,并正在推动市场成长。

製造成本高

製造玻璃安瓿需要复杂的製程和高品质的硼硅酸玻璃,而且价格昂贵。对纯度和安全性的严格监管要求进一步加剧了这些成本,这需要先进的技术和严格的品管措施。因此,整体製造成本明显较高。小型製药公司,尤其是新兴市场的小型製药公司,可能难以满足这些高成本,这限制了注射药物的生产和分销并阻碍了市场成长。

环保考量

对永续性的日益关注为药用玻璃安瓿市场创造了机会。玻璃是一种可回收材料,使其成为比某些塑胶包装更环保的选择。随着消费者和医疗保健提供者的环保意识越来越强,对玻璃安瓿等永续包装解决方案的需求可能会增加。因此,玻璃安瓿提供了一种展示对环境责任的承诺的方式,并有可能吸引具有环保意识的客户。

自动化可能性有限

玻璃安瓿製造涉及复杂的流程,难以完全自动化,并且严重依赖技术纯熟劳工进行品管和封装等精密操作。此外,缺乏自动化会减慢生产速度,阻碍满足不断增长的药品需求的能力,特别是在流行病和健康危机等激增期间。这些低效率可能导致供应链中断和基本药物交付延迟,从而影响医疗保健提供者和患者。

COVID-19 的影响

疫苗和注射药物需求的激增导致药用玻璃安瓿产量增加,以支持大规模免疫宣传活动和治疗行动。然而,全球供应链和製造业务的中断最初成为一个问题,导致供不应求。此外,对疫苗分发和储存的需求不断增加,凸显了可靠、高品质玻璃安瓿的重要性。

预计直管安瓿细分市场在预测期间规模最大

随着对更安全、更方便的包装的需求不断增加,直管安瓿预计在预测期内将以最高销售量成长。对于希望在药用玻璃安瓿市场上实现产品差异化的製造商来说,直管安瓿代表着竞争优势。其独特的设计和安全性可以吸引寻求创新解决方案的医疗提供者和製药公司。

中性玻璃安瓿细分市场预计在预测期内复合年增长率最高

中性玻璃安瓿具有优异的耐化学性,使其适合储存多种药物配方,包括酸性、碱性和中性化合物。这种多功能性使製药公司能够在各种配方中使用中性玻璃安瓿,从而扩大市场覆盖范围。

比最大的地区

由于慢性病增加、注射药物需求增加以及对安全可靠的包装解决方案的需求有助于市场扩张等因素,预计北美将在预测期内占据最大的市场占有率。此外,玻璃製造流程的技术进步、严格的监管标准以及主要市场参与企业的存在进一步刺激了市场成长。

复合年增长率最高的地区:

随着中国建立製药业的标准框架,预计亚太地区在预测期内将保持最高的复合年增长率。国家越来越注重药品包装材料在药品储存过程中的稳定性以及包装在使用过程中的安全性。由于玻璃包装的耐用性、非反应性、透明度、环境相容性和多功能性,製药公司越来越多地转向玻璃包装。此外,由于医疗保健系统投资增加、研发增加以及药品成本增加,管瓶的需求量很大。

免费客製化服务

订阅此报告的客户可以利用以下免费自订选项之一:

  • 公司简介
    • 其他市场参与企业的综合分析(最多 3 家公司)
    • 主要企业SWOT分析(最多3家企业)
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计/预测/复合年增长率(註:基于可行性检查)
  • 竞争基准化分析
    • 按产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行概述

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 介绍
  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球药用玻璃安瓿市场:依产品类型

  • 介绍
  • 直桿安瓿
  • 漏斗形安瓿
  • 灯泡形安瓿
  • 刻划安瓿
  • 开口安瓿
  • 色环 (CBR) 安瓿

第六章全球药用玻璃安瓿市场:按类型

  • 介绍
  • 中性玻璃安瓿
  • 彩色玻璃安瓿
  • 印有标记的安瓿

第七章全球药用玻璃安瓿市场:依容量分类

  • 介绍
  • 小容量(2ml以下)
  • 中等容量(2-6ml)
  • 大容量(6ml以上)

第八章全球药用玻璃安瓿市场:按应用

  • 介绍
  • 注射液
  • 冻干(冻干)药品
  • 疫苗
  • 美容液
  • 其他的

第九章全球药用玻璃安瓿市场:依最终用户分类

  • 介绍
  • 製药公司
  • 生技公司
  • 临床研究所
  • 医院和诊所
  • 契约製造组织 (CMO)
  • 其他的

第十章全球药用玻璃安瓿市场:按地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东/非洲

第十一章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • AAPL Solutions Pvt. Ltd
  • Accu-Glass LLC
  • Adit Containers Private Limited
  • Agrado SA
  • Birgimefar Group
  • BOROSIL
  • CORNING INCORPORATED
  • Gerresheimer AG
  • J. Penner Corporation
  • Kapoor Glass India Pvt. Ltd
  • NIPRO Corporation
  • Schott AG
  • SGD SA(SGD Pharma)
  • Shandong Pharmaceutical Glass Co. Ltd
  • Sm Pack SpA
  • Stevanato Group SPA
  • Stoelzle Oberglas GmbH
  • Zhengchuan Pharmaceutical Packaging
Product Code: SMRC26398

According to Stratistics MRC, the Global Pharmaceutical Glass Ampoules Market is accounted for $14.8 billion in 2024 and is expected to reach $24.7 billion by 2030 growing at a CAGR of 8.9% during the forecast period. Pharmaceutical glass ampoules are small, sealed vials made from glass, used to contain and preserve liquid medications, especially for injectable purposes. These ampoules are typically made from high-quality borosilicate glass, which offers excellent chemical resistance and thermal stability, ensuring the purity and stability of the contained pharmaceutical products. The glass material prevents interaction between the drug and the container, maintaining the efficacy and safety of the medication. This is widely used in hospitals and clinical settings, pharmaceutical glass ampoules are crucial for delivering vaccines, injectable drugs, and other critical medications safely and effectively.

According to CNN and OWID, as of March 20, 2023, about 13 billion COVID-19 vaccine doses had been administered globally, with the United States accounting for almost 672 million.

Market Dynamics:

Driver:

Rising Demand for Pharmaceuticals

The growing trend towards single-dose packaging in pharmaceuticals aligns perfectly with the strengths of glass ampoules. Single-dose packaging minimizes the risk of medication contamination and ensures precise dosage administration. Glass ampoules provide a convenient and safe solution for this growing market segment. Moreover many medications, particularly those derived from biotechnology or containing delicate components, require packaging that offers superior protection against factors like moisture, air, and light degradation. Glass ampoules, with their excellent barrier properties and chemical inertness, are ideal for this sensitive drug drives the growth of the market.

Restraint:

High cost of production

Manufacturing glass ampoules involves complex processes and high-quality borosilicate glass, which can be expensive. These costs are further compounded by stringent regulatory requirements for purity and safety, necessitating advanced technology and rigorous quality control measures. As a result, the overall production costs are significantly high. Smaller pharmaceutical companies, particularly in developing regions, might struggle to afford these higher costs, limiting their ability to produce or distribute injectable medications effectively hampers the growth of the market.

Opportunity:

Eco-friendly considerations

The growing focus on sustainability presents an opportunity for the pharmaceutical glass ampoule market. Glass is a recyclable material, making it an eco-friendly alternative compared to some plastic packaging options. As consumers and healthcare institutions become more environmentally conscious, the demand for sustainable packaging solutions like glass ampoules could rise. Thus glass ampoules can be a way to showcase a commitment to environmental responsibility, potentially attracting environmentally conscious customers.

Threat:

Limited automation potential

Manufacturing glass ampoules involves intricate processes that are difficult to fully automate, relying heavily on skilled labor for precision tasks like quality control and sealing. Additionally, the lack of automation leads to slower production rates, hindering the ability to meet the growing demand for pharmaceutical products, especially during surges such as during pandemics or health crises. This inefficiency can result in supply chain disruptions and delays in the delivery of essential medications, impacting healthcare providers and patients.

Covid-19 Impact

The surge in demand for vaccines and injectable medications led to increased production of pharmaceutical glass ampoules to accommodate mass vaccination campaigns and treatment efforts. However, disruptions in global supply chains and manufacturing operations initially posed challenges, resulting in supply shortages. Additionally, heightened focus on vaccine distribution and storage requirements emphasized the importance of reliable and high-quality glass ampoules.

The straight-stem ampoules segment is expected to be the largest during the forecast period

The straight-stem ampoules is expected to be the largest during the forecast period as the demand for safer and more user-friendly packaging grows, straight-stem ampoules offer a competitive advantage for manufacturers looking to differentiate their products in the Pharmaceutical Glass Ampoules market. Their unique design and safety features can attract healthcare providers and pharmaceutical companies seeking innovative solutions.

The neutral glass ampoules segment is expected to have the highest CAGR during the forecast period

The neutral glass ampoules segment is expected to have the highest CAGR during the forecast period owing to the chemical resistance of neutral glass makes it suitable for storing a diverse range of pharmaceutical formulations, including acidic, basic, and neutral compounds. This versatility allows pharmaceutical companies to use neutral glass ampoules for various drug formulations, expanding their market applicability.

Region with largest share:

North America is projected to hold the largest market share during the forecast period owing to factors such as the increasing prevalence of chronic diseases, rising demand for injectable medications, and the need for secure and reliable packaging solutions contribute to market expansion. Additionally, technological advancements in glass manufacturing processes, stringent regulatory standards, and the presence of key market players further stimulate market growth.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period as China has established a standard framework for the pharmaceutical industry. The country is increasingly focusing on the stability of pharmaceutical packaging materials during drug storage and the safety of the packaging when used. Pharmaceutical companies increasingly use glass packaging because of its durability, non-reactivity, transparency, eco-friendliness, and versatility. Additionally, glass vials are in high demand due to increasing investment and R&D in healthcare systems and rising drug spending.

Key players in the market

Some of the key players in Pharmaceutical Glass Ampoules market include AAPL Solutions Pvt. Ltd, Accu-Glass LLC, Adit Containers Private Limited, Agrado SA, Birgimefar Group, BOROSIL, CORNING INCORPORATED, Gerresheimer AG, J. Penner Corporation, Kapoor Glass India Pvt. Lt, NIPRO Corporation, Schott AG, SGD SA (SGD Pharma), Shandong Pharmaceutical Glass Co. Ltd, Sm Pack SpA, Stevanato Group SPA, Stoelzle Oberglas GmbH and Zhengchuan Pharmaceutical Packaging

Key Developments:

In April 2024, SCHOTT launches pilot projects on glass-ceramics and specialty glass for a more circular economy. The circular economy a joint challenge for policymakers and the specialty glass industry

In March 2024, Stevanato Group Unveils New Plant in Cisterna di Latina for the Production of Pre-Sterilized EZ-fill(R) Syringes and Cartridges, the facility started commercial production in Q4 2023 and houses advanced production lines developed by Stevanato Group for the production of EZ-fill(R) pre-sterilized syringes

In March 2024, Stevanato Group Announces Closing of Upsized Public Offering of Ordinary Shares and Exercise in Full of the Underwriters' Option to Purchase Additional Ordinary Shares. The total gross proceeds from the Offering, before deducting underwriting discounts and commissions

Product Types Covered:

  • Straight-Stem Ampoules
  • Funnel-Type Ampoules
  • Bulb-Shaped Ampoules
  • Score Ring Ampoules
  • Open-Tip Ampoules
  • Color Break Ring (CBR) Ampoules

Types Covered:

  • Neutral Glass Ampoules
  • Ampoules with Colored Glass
  • Ampoules with Printed Markings

Capacities Covered:

  • Small capacity (up to 2ml)
  • Medium capacity (2ml to 6ml)
  • Large capacity (more than 6ml)

Applications Covered:

  • Injectable Solutions
  • Lyophilized (Freeze-Dried) Drugs
  • Vaccines
  • Serums
  • Other Applications

End Users Covered:

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Clinical Research Organizations
  • Hospitals and Clinics
  • Contract Manufacturing Organizations (CMOs)
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Pharmaceutical Glass Ampoules Market, By Product Type

  • 5.1 Introduction
  • 5.2 Straight-Stem Ampoules
  • 5.3 Funnel-Type Ampoules
  • 5.4 Bulb-Shaped Ampoules
  • 5.5 Score Ring Ampoules
  • 5.6 Open-Tip Ampoules
  • 5.7 Color Break Ring (CBR) Ampoules

6 Global Pharmaceutical Glass Ampoules Market, By Type

  • 6.1 Introduction
  • 6.2 Neutral Glass Ampoules
  • 6.3 Ampoules with Colored Glass
  • 6.4 Ampoules with Printed Markings

7 Global Pharmaceutical Glass Ampoules Market, By Capacity

  • 7.1 Introduction
  • 7.2 Small capacity (up to 2ml)
  • 7.3 Medium capacity (2ml to 6ml)
  • 7.4 Large capacity (more than 6ml)

8 Global Pharmaceutical Glass Ampoules Market, By Application

  • 8.1 Introduction
  • 8.2 Injectable Solutions
  • 8.3 Lyophilized (Freeze-Dried) Drugs
  • 8.4 Vaccines
  • 8.5 Serums
  • 8.6 Other Applications

9 Global Pharmaceutical Glass Ampoules Market, By End User

  • 9.1 Introduction
  • 9.2 Pharmaceutical Companies
  • 9.3 Biotechnology Companies
  • 9.4 Clinical Research Organizations
  • 9.5 Hospitals and Clinics
  • 9.6 Contract Manufacturing Organizations (CMOs)
  • 9.7 Other End Users

10 Global Pharmaceutical Glass Ampoules Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 AAPL Solutions Pvt. Ltd
  • 12.2 Accu-Glass LLC
  • 12.3 Adit Containers Private Limited
  • 12.4 Agrado SA
  • 12.5 Birgimefar Group
  • 12.6 BOROSIL
  • 12.7 CORNING INCORPORATED
  • 12.8 Gerresheimer AG
  • 12.9 J. Penner Corporation
  • 12.10 Kapoor Glass India Pvt. Ltd
  • 12.11 NIPRO Corporation
  • 12.12 Schott AG
  • 12.13 SGD SA (SGD Pharma)
  • 12.14 Shandong Pharmaceutical Glass Co. Ltd
  • 12.15 Sm Pack SpA
  • 12.16 Stevanato Group SPA
  • 12.17 Stoelzle Oberglas GmbH
  • 12.18 Zhengchuan Pharmaceutical Packaging

List of Tables

  • Table 1 Global Pharmaceutical Glass Ampoules Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Pharmaceutical Glass Ampoules Market Outlook, By Product Type (2022-2030) ($MN)
  • Table 3 Global Pharmaceutical Glass Ampoules Market Outlook, By Straight-Stem Ampoules (2022-2030) ($MN)
  • Table 4 Global Pharmaceutical Glass Ampoules Market Outlook, By Funnel-Type Ampoules (2022-2030) ($MN)
  • Table 5 Global Pharmaceutical Glass Ampoules Market Outlook, By Bulb-Shaped Ampoules (2022-2030) ($MN)
  • Table 6 Global Pharmaceutical Glass Ampoules Market Outlook, By Score Ring Ampoules (2022-2030) ($MN)
  • Table 7 Global Pharmaceutical Glass Ampoules Market Outlook, By Open-Tip Ampoules (2022-2030) ($MN)
  • Table 8 Global Pharmaceutical Glass Ampoules Market Outlook, By Color Break Ring (CBR) Ampoules (2022-2030) ($MN)
  • Table 9 Global Pharmaceutical Glass Ampoules Market Outlook, By Type (2022-2030) ($MN)
  • Table 10 Global Pharmaceutical Glass Ampoules Market Outlook, By Neutral Glass Ampoules (2022-2030) ($MN)
  • Table 11 Global Pharmaceutical Glass Ampoules Market Outlook, By Ampoules with Colored Glass (2022-2030) ($MN)
  • Table 12 Global Pharmaceutical Glass Ampoules Market Outlook, By Ampoules with Printed Markings (2022-2030) ($MN)
  • Table 13 Global Pharmaceutical Glass Ampoules Market Outlook, By Capacity (2022-2030) ($MN)
  • Table 14 Global Pharmaceutical Glass Ampoules Market Outlook, By Small capacity (up to 2ml) (2022-2030) ($MN)
  • Table 15 Global Pharmaceutical Glass Ampoules Market Outlook, By Medium capacity (2ml to 6ml) (2022-2030) ($MN)
  • Table 16 Global Pharmaceutical Glass Ampoules Market Outlook, By Large capacity (more than 6ml) (2022-2030) ($MN)
  • Table 17 Global Pharmaceutical Glass Ampoules Market Outlook, By Application (2022-2030) ($MN)
  • Table 18 Global Pharmaceutical Glass Ampoules Market Outlook, By Injectable Solutions (2022-2030) ($MN)
  • Table 19 Global Pharmaceutical Glass Ampoules Market Outlook, By Lyophilized (Freeze-Dried) Drugs (2022-2030) ($MN)
  • Table 20 Global Pharmaceutical Glass Ampoules Market Outlook, By Vaccines (2022-2030) ($MN)
  • Table 21 Global Pharmaceutical Glass Ampoules Market Outlook, By Serums (2022-2030) ($MN)
  • Table 22 Global Pharmaceutical Glass Ampoules Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 23 Global Pharmaceutical Glass Ampoules Market Outlook, By End User (2022-2030) ($MN)
  • Table 24 Global Pharmaceutical Glass Ampoules Market Outlook, By Pharmaceutical Companies (2022-2030) ($MN)
  • Table 25 Global Pharmaceutical Glass Ampoules Market Outlook, By Biotechnology Companies (2022-2030) ($MN)
  • Table 26 Global Pharmaceutical Glass Ampoules Market Outlook, By Clinical Research Organizations (2022-2030) ($MN)
  • Table 27 Global Pharmaceutical Glass Ampoules Market Outlook, By Hospitals and Clinics (2022-2030) ($MN)
  • Table 28 Global Pharmaceutical Glass Ampoules Market Outlook, By Contract Manufacturing Organizations (CMOs) (2022-2030) ($MN)
  • Table 29 Global Pharmaceutical Glass Ampoules Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.